Literature DB >> 9755381

Maximizing the hemodynamic benefit of enhanced external counterpulsation.

K Suresh1, S Simandl, W E Lawson, J C Hui, O Lillis, L Burger, T Guo, P F Cohn.   

Abstract

BACKGROUND: Enhanced external counterpulsation (EECP) has been demonstrated to be an effective treatment for angina and exertional ischemia in patients with coronary disease. HYPOTHESIS: It is hypothesized that the ability of EECP to enhance the recruitment or development of coronary collaterals in coronary artery disease may be determined by the relative magnitude of diastolic augmentation (DA) and systolic unloading (SU). This study examines the relation between the proposed EECP effectiveness ratio (DA/SU), as assessed by finger plethysmography, and changes in descending aortic flow as assessed by Doppler echocardiography in 15 patients during EECP.
METHODS: Varying external cuff pressures (0-275 mmHg) were used to generate a range of DA/SU ratios. The effect on aortic antegrade systolic and retrograde diastolic flow was assessed by Doppler echocardiography to determine whether there was an optimal EECP effectiveness ratio that maximizes the hemodynamic effects of EECP. With increasing DA/SU there was an initial positive linear increase in both systolic and diastolic flow volume. Systolic flow maximized at an effectiveness ratio of 1.5 and diastolic flow at a ratio of 2.0 RESULT: Therefore, effectiveness ratios (DA/SU) in the range of 1.5-2.0 are optimal for maximizing the hemodynamic effects of EECP.

Entities:  

Mesh:

Year:  1998        PMID: 9755381      PMCID: PMC6655932          DOI: 10.1002/clc.4960210908

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction.

Authors:  Darren T Beck; Jeffrey S Martin; Darren P Casey; Joseph C Avery; Paloma D Sardina; Randy W Braith
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-09       Impact factor: 2.557

2.  A novel external counterpulsation system for coronary artery disease and heart failure: pilot studies and initial clinical experiences.

Authors:  Tsuyoshi Shimizu; Shunei Kyo; Kazuhito Imanaka; Kohei Nakaoka; Etsuji Nishimura; Takahiro Okumura; Masaaki Ishii; Motoyuki Hisagi; Takashi Nishimura; Noboru Motomura; Minoru Ono; Shinichi Takamoto
Journal:  J Artif Organs       Date:  2010-08-25       Impact factor: 1.731

3.  Enhanced external counterpulsation for refractory angina pectoris.

Authors:  R M Sinvhal; R M Gowda; I A Khan
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

4.  Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure.

Authors:  André Erdling; Susanne Bondesson; Thomas Pettersson; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2008-12-18       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.